<DOC>
	<DOCNO>NCT02245373</DOCNO>
	<brief_summary>Major Depression ( MD ) highly prevalent associate high burden economic cost . Mild level MD could treat without antidepressant Primary Care ( PC ) . Main objective : 1 ) To calculate cost-effectiveness active monitoring ( recommended NICE ) v pharmacological antidepressant treatment treat mild MD PC level . Methods : 300 patient ( ≥18 year ) MD ( diagnose GP ) recruit PC center . Depending level symptom , GP choose : A ) Active Monitoring ( n=150 ) B ) pharmacological treatment ( n=150 ) . Patients followed-up one year data collect baseline , 6 12 month . Severity assess Patient Health Questionnaire ( PHQ-9 ) , quality life EuroQoL-5D ( 5 health dimension ) , use service adapt version Client Service Receipt Inventory ( include lose productivity ) . Cost-effectiveness cost-utility analysis calculate 5000 bootstrapping replication conduct ass uncertainty . Cost-acceptability curve do use two perspective : National Health Service perspective Societal perspective . The Propensity Score technique minimize absence randomization , match case treatment option .</brief_summary>
	<brief_title>Cost-effectiveness Non-Pharmacological Treatment ( Active Monitoring ) vs. Pharmacological Treatment Major Depression Primary Care .</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>1 . Patients whose GP consider major depression . The indication pharmacological nonpharmacological treatment base strictly clinical judgment physician . 2 . Adults ( ≥18 year ) 3 . Informed consent sign physician patient participate study . 1 . Use antidepressant drug previous 60 day inclusion date . 2 . Alcohol toxic abuse . 3 . Psychosis bipolar disorder identify psychiatric interview 4 . Use last 6 month antipsychotic drug , lithium antiepileptic 5 . Health status ( pregnancy ) / disease / treatment contraindicate use antidepressant drug . 6 . Terminal illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Depression</keyword>
	<keyword>Primary Care</keyword>
	<keyword>Cost-effectiveness</keyword>
	<keyword>Pharmacological treatment</keyword>
	<keyword>Watchful-waiting Active Monitoring .</keyword>
</DOC>